Document ID: chunk:federal_register_of_legislation:F2024C01228:reg:305b
Version: federal_register_of_legislation:F2024C01228
Segment Type: reg
Provision Reference: reg 305B
Character Range: 138751–141983

305B   Vaccine                                                                                                                    Vaxelis®        Injection (0.5mL)                   Each of the following:                                                                   3 doses
       Diphtheria, tetanus, pertussis and poliomyelitis, hepatitis B, and Haemophilus influenzae type b (DTPa‑HB‑IPV‑Hib)                                                              (a) diphtheria toxoid — not less than 20 IU;
                                                                                                                                                                                       (b) tetanus toxoid — not less than 40 IU;
       Circumstances                                                                                                                                                                   (c) PT — 20 µg;
       Vaccine may be provided to a child who is about 2, 4 and 6 months old, from 6 weeks of age.                                                                                     (d) FHA — 20 µg;
                                                                                                                                                                                       (e) PRN — 3 µg;
                                                                                                                                                                                         (f)   FIM — 3 µg;
                                                                                                                                                                                         (g)    Hepatitis B surface antigen— 10 µg;
                                                                                                                                                                                       (h) inactivated poliovirus type 1 (Mahoney) — 40 D‑antigen units;
                                                                                                                                                                                       (i) inactivated poliovirus type 2 (MEF‑1) — 8 D‑antigen units;
                                                                                                                                                                                       (j) inactivated poliovirus type 3 (Saukett) —32 D‑antigen units
                                                                                                                                                                                       (k) hepatitis B surface antigen — 10 µg;
                                                                                                                                                                                       (l) Haemophilus influenzae type b polysaccharide (Polyribosylribitol Phosphate) — 3 µg
                                                                                                                                                                                          (m) Conjugated to meningococcal protein2 — 50 µg